2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment

2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment
The University of Hawaiʻi Cancer Center is enrolling participants in two clinical trials to test new ways of preventing and diagnosing breast cancer, as well as improving current treatments. “These trials are very important because breast cancer is a significant issue in Hawaiʻi,” Randall Holcombe, director of the UH Cancer Center said in a press release. “Racial and ethnic minority groups are severely under-represented in breast cancer clinical trials in the rest of the United States, so participation of patients from Hawaiʻi is doubly important.” The two trials are being coordinated by the university, but patients will be enrolled at sites across the U.S. and some parts of Canada. A Phase 3 trial (NCT02927249), called Aspirin Breast Cancer (ABC), currently recruiting participants, will assess if aspirin may help prevent cancer from recurring in patients with node-positive, human growth factor receptor 2 (HER2)-negative breast cancer. Patients in the trial must have received standard therapy — which usually involves sequential chemotherapy to shrink the tumor, surgery to remove it, and radiation therapy to eliminate any potentially remai
Subscribe or to access all post and page content.